Academic Partnerships Active collaboration with the University of Mississippi on a poison ivy vaccine signals readiness for expanded academic partnerships, licensing discussions, or sponsored research with other universities or biotech firms.

Funding Opportunities Revenue appears modest, indicating early-stage status and a potential need for external funding; opportunities include pursuing grants, strategic licensing of the PDC-APB program, or partnerships with biotech investors.

CRO and Regulatory With a small team, Hapten Sciences will likely rely on outsourced CROs, regulatory consultants, and contract manufacturers; vendors offering preclinical services, regulatory support, and GMP manufacturing could be well positioned.

Niche Vaccine Value The poison ivy vaccine focus places Hapten Sciences in a niche dermatology immunology space, creating licensing or co development opportunities with larger pharma players seeking to broaden their dermatology vaccine portfolios.

Digital and Outreach An existing digital footprint based on common web technologies suggests opportunities for marketing optimization, partner enablement, and secure hosting; IT and marketing service providers could help scale outreach and collaboration with potential partners.